Contact this trialFirst, we need to learn more about you.
Belantamab Mafodotin for Multiple Myeloma
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing if belantamab mafodotin can help prevent multiple myeloma from returning after a stem cell transplant. It focuses on patients who have had this transplant and are at risk of relapse. The drug works by targeting and killing cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service